2023-04-11 722
On the morning of April 7, 2023, the company organized the Sales Work Conference of the Marketing Center. Chairman Huang Yi, General Manager of the Marketing Center Wu Yongzhi, Vice President of Quality and Director of the Research Institute Chen Min, Vice President of Finance Yi Chun, Zhang Xiaopeng from the Quality Control Department, Deng Xueqin from the Customer Service Department, Vice Presidents of the Marketing Center Wang Qiang, Cheng Weiqi, Sun Jingjun, Zhang Rui, Huang Yujun, and Cai Jingjing, as well as the Market Department Manager Zhong Chunyan, and managers from the Provincial Investment Promotion Department, attended the meeting.
Chairman Huang Yi is a visionary leader with great wisdom and foresight. With nearly forty years of pharmaceutical enterprise management experience and progressive management abilities, as well as a forward-looking vision, he has provided our company with a clear direction for future development. He is the guiding soul and guiding light of our company. In the next five years, Zhuhai Tongyuan Pharmaceuticals Co., Ltd. will launch powerful high-tech products such as Oseltamivir Phosphate Capsules, Diquatsine Chloride Tablets, Topiroxostat Tablets, Formoterol Fumarate and Tiotropium Bromide Inhalation Powder, Fosaprepitant Dimeglumine for Injection, and Anti-HPV Gel, to promote the strong development of the company with the goal of "having lofty aspirations and making steady progress".
General Manager Wu Yongzhi of the Marketing Center, with the theme "Self-Transformation, Creating the Future," introduced the management transformation of organizational and assessment models, and made a profound analysis of the ideological transformation. He encouraged the marketing center team to embrace and adapt to the transformation, break through obstacles, and innovate themselves. Zhuhai Tongyuan Pharmaceuticals is our home, our platform, and our future. Under the leadership of Chairman Huang Yi, we will forge ahead together and create the future.
Zhong Chunyan provided training and market analysis on products such as Compound Potassium Phosphate Injection (Doninglang), Chloride Sodium Injection of Changchun Xitine, Aminophylline Hydrobromide Dispersible Tablets, and Calcium Carbonate Tablets.
Sales managers from various provinces summarized their sales work and market planning for their respective regions. On the 8th, Chairman Huang Yi, General Manager Wu Yongzhi, Vice President of Zone 1 Wang Qiang, Vice President of Zone 2 Cheng Weiqi, Vice President of Zone 3 Sun Jingjun, Vice President of Zone 4 Zhang Rui, Vice President of Zone 5 Huang Yujun, and corresponding regional sales managers had intense discussions on the development progress and methods of Compound Potassium Phosphate Injection, the development prospects of Oseltamivir Phosphate Capsules/Diquatsine Chloride Tablets, and the development of three end markets. They researched efficient and feasible sales strategies to support the upcoming sales work and create a new situation.
The Sales Work Conference of the Marketing Center was a complete success. We would like to express our gratitude to the relevant leaders and colleagues in the factory, as well as the hard work of the organizing committee!
Next, our marketing center team will redouble our efforts, set off again, and march forward together in a new journey!